Cardiac Pacemakers Market Size to Grow Steadily, Projected to Hit $6.51 Billion by 2029 at 6.9% CAGR

The Business Research Company’s report on the Cardiac Pacemakers Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.

What are the primary drivers fueling the growth of the cardiac pacemakers market in recent years?

An increase in cardiovascular diseases is significantly contributing to the growth of the cardiac pacemaker market. Cardiovascular disease (CVD) refers to disorders that affect the heart or blood vessels. These include arrhythmias, aorta disease, congenital heart disease, heart attack, and others. Cardiac pacemakers are electric activity-generating devices that are used to treat patients suffering from cardiovascular diseases. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. . Therefore, the rising incidence of cardiovascular diseases will drive the growth of the cardiac pacemaker market.

Access Your Free Sample of the Global Cardiac Pacemakers Market Report – Get Insights Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=7507&type=smp

What is the projected market size of the cardiac pacemakers industry, and how is it expected to grow?

The cardiac pacemakers market size has grown strongly in recent years. It will grow from $4.73 billion in 2024 to $4.98 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to aging population and the prevalence of cardiovascular diseases, growing awareness of arrhythmias and the need for treatment, investment in research and development for pacemaker innovation, evolving healthcare infrastructure and access to medical devices, and regulatory approvals for novel pacemaker features and technologies.

The cardiac pacemakers market size is expected to see strong growth in the next few years. It will grow to $6.51 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to focus on lead durability and reduction of complications, remote programming and telehealth services for pacemaker patients, expansion of emerging markets and rising healthcare expenditure, enhanced battery technologies for longer pacemaker lifespans, and regulatory support for expedited pacemaker approvals. Major trends in the forecast period include electrophysiology advancements for precision implantation, integration of pacemaker data into electronic health records (ehrs), integration of artificial intelligence (ai) for predictive pacemaker maintenance, advancements in pacemaker technology, including miniaturization, and telemedicine and remote monitoring.

Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=7507&type=smp

Who are the key players driving competition in the cardiac pacemakers market?

Major companies operating in the cardiac pacemakers market include Medtronic plc, Lepu Medical Technology Co., Abbott Inc., Biotronik SE & Co. KG, Boston Scientific Corporation, Oscor Inc., Osypca Medical GmbH, Zoll Medical Corporation, MicroPort Scientific Corporation, Cook Group Incorporated, Sorin Group, Vitatron & Medical Co., Cordis Inc., Shree Pacetronix Limited, Medico SpA, St. Jude Medical, LivaNova PLC, Schiller AG, BTL Industries Inc., CCC Medical Devices, Cardiostim, Advena Ltd., Mediana Co. Ltd., Vimecon GmbH, Cardiac Science Corporation, Greatbatch Medical, Galix Biomedical Instrumentation, Nanjing MicroPort Medical, Cardionovum GmbH

What key trends are expected to drive the canned meat market during the forecast period?

New innovations are a key trend in the cardiac pacemaker market. Major players are making innovations like leadless cardiac pacemakers to cater to the cardiac pacemaker market in a better way. The leadless pacemaker is a self-contained generator and electrode system and is 90% smaller than a transvenous pacemaker implanted immediately into the right ventricle. There is no need for a chest incision or subcutaneous generator pocket because the device is placed via a femoral vein transcatheter technique is a minimally invasive technique to repair an inadequately opening narrowed aortic valve. For instance, in January 2022, Medtronic PLC., an Ireland-based medical devices company, introduced their leadless pacemaker Micra AV Transcatheter Pacing System (TPS). The Micra AV helps in patients’ treatment with AV block when the electrical communication between the heart’s ventricle and atria is compromised.

Which key geographies are driving the growth of the cardiac pacemakers market?

North America was the largest region in the cardiac pacemakers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac pacemakers market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Order Your Report Now For Swift Delivery

https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report

What are the key segments driving growth in the cardiac pacemakers market?

The cardiac pacemakers market covered in this report is segmented –

1) By Type: Implantable, External

2) By Technology: Biventricular, Single Chambered, Dual Chambered

3) By Application: Arrhythmias, Heart Blockage, Atrial Fibrillation, Long QT Syndrome, Congestive Cardiac Failure, Other Applications

4) By End User: Clinics And Hospitals, Ambulatory Surgical Centers, Cardiac Care Centers

Subsegments:

1) By Implantable: Single Chamber Pacemakers, Dual Chamber Pacemakers, Biventricular Pacemakers (CRT-P), Leadless Pacemakers

2) By External: Transcutaneous Pacemakers, Transvenous Pacemakers

Purchase The Exclusive Report Now To Unlock Valuable Market Insights:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7507

How is the cardiac pacemakers market defined?

A cardiac pacemaker refers to a small electronic device that generates electrical impulses and prevents the heart from beating too fast or slow and helps in treating heart conditions such as arrhythmias is a heart condition where the heart beats irregularly. The cardiac pacemakers are used to maintain the rhythm of heartbeats.

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Leave a Reply

Your email address will not be published. Required fields are marked *